Scientists dig into DNA of rare gut cancer to improve prognosis

NCT ID NCT07587268

Recruiting now Knowledge-focused Sponsor: City of Hope Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study looks at stored tumor samples from 400 people with appendiceal cancer. Researchers will analyze DNA and RNA modifications to find patterns linked to how the cancer behaves. The goal is to create a molecular score that could one day help doctors predict outcomes more accurately than current methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could lead to better ways to predict how appendiceal cancer will behave, helping doctors tailor follow-up and treatment decisions.
What could go wrong: This is an observational study using stored tissue samples, not a treatment trial. The findings may not directly change patient care and need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APPENDICEAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

appendiceal neoplasm appendix adenocarcinoma appendix cancer appendix carcinoma mucinous adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APPENDICEAL ADENOCARCINOMA APPENDICEAL CANCER

Contacts and locations

Locations

City of Hope Medical Center
RECRUITING

Durate, California, 91016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.